These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1937993)
21. Comparative pharmacokinetics of two brands of atenolol following a single oral administration. Irshaid YM; Rawashdeh NM; Awwadi FF; Kato MK Int J Clin Pharmacol Ther; 1996 Oct; 34(10):457-61. PubMed ID: 8897086 [TBL] [Abstract][Full Text] [Related]
22. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers. Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993 [TBL] [Abstract][Full Text] [Related]
23. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers. Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990 [TBL] [Abstract][Full Text] [Related]
24. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses. Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082 [TBL] [Abstract][Full Text] [Related]
25. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring. Granberry MC; Gardner SF; Schneider EF; Carter IR Pharmacotherapy; 1996; 16(5):932-6. PubMed ID: 8888089 [TBL] [Abstract][Full Text] [Related]
26. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study. Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers. Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203 [TBL] [Abstract][Full Text] [Related]
28. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
29. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine? Toal CB J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays. Arafat T; Awad R; Hamad M; Azzam R; Al-Nasan A; Jehanli A; Matalka K J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045 [TBL] [Abstract][Full Text] [Related]
31. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers. Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215 [TBL] [Abstract][Full Text] [Related]
32. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737 [TBL] [Abstract][Full Text] [Related]
33. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC. Khan MK; Khan MF Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of nifedipine in Taiwanese. Chien SC; Uang YS; Lin HY; Hsu KY Biopharm Drug Dispos; 2004 Mar; 25(2):77-84. PubMed ID: 14872555 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers. Cho HY; Moon JD; Lee YB Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438 [TBL] [Abstract][Full Text] [Related]
36. Relative bioavailability of four controlled-release nifedipine products. Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987 [TBL] [Abstract][Full Text] [Related]
37. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration. Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994 [TBL] [Abstract][Full Text] [Related]
38. Average bioequivalence of two oral formulations of fluconazole in healthy subjects after multiple dosing. Atanasova I; Bozhinova K; Terziivanov D Int J Clin Pharmacol Ther; 1999 Jun; 37(6):282-5. PubMed ID: 10395119 [TBL] [Abstract][Full Text] [Related]
40. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]